Spinal Muscular Atrophy

Overview


Plain-Language Overview

Spinal Muscular Atrophy is a genetic disorder that affects the nervous system, specifically the nerve cells that control muscle movement. It causes progressive muscle weakness and loss of motor function, primarily in the arms and legs. This condition results from the loss of specialized nerve cells called motor neurons in the spinal cord. As these neurons die, muscles become weaker and may eventually waste away. The severity of symptoms can vary widely, but it often leads to difficulties with activities like walking, swallowing, and breathing. Early diagnosis is important to understand the progression and manage symptoms effectively.

Clinical Definition

Spinal Muscular Atrophy is a hereditary neuromuscular disorder characterized by degeneration of anterior horn cells in the spinal cord, leading to progressive muscle atrophy and weakness. It is most commonly caused by homozygous deletions or mutations in the SMN1 gene, which encodes the survival motor neuron (SMN) protein essential for motor neuron maintenance. The disease manifests with varying severity, classified into types based on age of onset and motor milestones achieved. The loss of motor neurons results in impaired voluntary muscle movement, predominantly affecting proximal muscles. Respiratory failure is a major cause of morbidity and mortality. Diagnosis is confirmed by genetic testing identifying biallelic SMN1 mutations. The condition is a leading genetic cause of infant mortality.

Inciting Event

Locked content.

Latency Period

Locked content.

Diagnostic Delay

Locked content.

Clinical Presentation


Signs & Symptoms

Locked content.

History of Present Illness

Locked content.

Past Medical History

Locked content.

Family History

Locked content.

Physical Exam Findings

Locked content.

Diagnostic Workup


Diagnostic Criteria

Locked content.

Pathophysiology


Key Mechanisms

Locked content.

Organs

Locked content.

Tissues

Locked content.

Cells

Locked content.

Chemical Mediators

Locked content.

Treatments


Pharmacological Treatments

Locked content.

Non-pharmacological Treatments

Locked content.

Prevention


Pharmacological Prevention

Locked content.

Non-pharmacological Prevention

Locked content.

Outcome & Complications


Complications

Locked content.

Short-term Sequelae

Locked content.

Long-term Sequelae

Locked content.

Differential Diagnoses


Differentials

Locked content.

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site's content were generated or assisted by AI. All material has been reviewed by Erik Romano, MD, however, errors or omissions may still occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. “USMLE Step 1” and “USMLE Step 2 CK” are used only to identify the relevant examinations.